PSMA targeting peptide TFA

(Synonyms: PSMA-1 TFA)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

PSMA targeting peptide (PSMA-1) TFA is a PSMA-binding peptide that selectively binds to the PSMA receptor on prostate cancer cells and acts as a peptide-based siRNA delivery system by complexing and releasing siRNA. PSMA targeting peptide TFA can be used in research on prostate cancer.

For research use only. We do not sell to patients.

  • Purity : 98.54%
  • Formula: C70H122N24O19.xC2HF3O2
  • Molecular Weight:1603.87 (free base)
  • Storage:

    Sealed storage, away from moisture and light.

    Powder   -80°C, 2 years , -20°C, 1 year

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) PSMA targeting peptide TFA

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00